Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 650,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently.
With more than 25 years’ experience as a cell therapy CDMO and more than 40 years of expereince as a testing provider, we are a trusted partner for scalability, high quality results, and cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies.
Minaris Advanced Therapies is wholly owned by Altaris, LLC.
Company Details
- Employees
- 833
- Founded
- -
- Address
- 400 Rouse Blvd, Philadelphia,pennsylvania 19112,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.minaris.com
- Keywords
- cGMP Commercial Manufacturing, cGMP Process, Product, and Assay Development, GTP Cell and Tissue Processing and Sourcing, cGMP/GTP Cryostorage, Regenerative Medicine, Cell Therapy, Gene Therapy, Viral Vector Product.
- HQ
- Philadelphia, Pennsylvania
Minaris Advanced Therapies Questions
Minaris Advanced Therapies's website is http://www.minaris.com
Minaris Advanced Therapies's LinkedIn profile is https://www.linkedin.com/company/minaris-advanced-therapies
Minaris Advanced Therapies has
833 employees.
View email and phone details for 833
employees at Minaris Advanced Therapies.
Minaris Advanced Therapies's industry is
Pharmaceutical Manufacturing
Minaris Advanced Therapies's top competitors are
Made Scientific,
Bristol Myers Squibb,
Minaris Regenerative Medicine Gmbh,
Advanced Therapies, Llc,
Novartis,
Catalent,
Iovance Biotherapeutics, Inc.,
Legend Biotech,
Altaris, Llc.
Minaris Advanced Therapies's categories are Pharmaceutical Manufacturing
Minaris Advanced Therapies's founding year is 2025
